| Feb 7, 11 | Arm and mining groups help lift FTSE 100 to a three week high | | No data |
| Feb 4, 11 | AstraZeneca slips as Brilinta faces six month wait for possible US approval | | No data |
| Jan 30, 11 | Pfizer forced to deny reports of avoiding VAT in Germany | | No data |
| Jan 27, 11 | AstraZeneca pins hope on diabetes drug | | No data |
| Jan 27, 11 | FTSE dips on S&P's Japan downgrade, but results lift AstraZeneca | | No data |
| Jan 24, 11 | Ready cash tempts Northern Foods investors | | No data |
| Jan 24, 11 | Defensive moves push FTSE up | | No data |
| Jan 21, 11 | AstraZeneca bolstered by Brilinta hopes as FTSE 100 recovers some lost ground | | No data |
| Jan 21, 11 | AstraZeneca adds 1% on new Brilinta hopes, as FTSE 100 rebounds | | No data |
| Jan 14, 11 | AstraZeneca's Brilinta could benefit from problems at rival Merck | | No data |
| Jan 7, 11 | FTSE falls on Eurozone worries but InterContinental climbs on disposal hopes | | No data |
| Dec 23, 10 | FTSE breaches 6000 before falling back, but AstraZeneca climbs despite drug disappointment | | No data |
| Dec 23, 10 | AstraZeneca shares shrug off third drug disappointment in a week | | No data |
| Dec 21, 10 | AstraZeneca takes $445m charge after lung disease drug disappointment | | No data |
| Dec 17, 10 | AstraZeneca blockbuster Brilinta fails to win FDA approval | | No data |
| Dec 17, 10 | AstraZeneca drops nearly 5% after US fails to approve Brilinta drug | | No data |
| Nov 19, 10 | AstraZeneca ponders $2bn sale of dental subsidiary | | No data |
| Nov 17, 10 | FTSE 100 edges up as Irish aid package moves closer | | No data |
| Nov 16, 10 | FTSE suffers biggest one day points fall since June on worries over Ireland and Chinese rate rise | | No data |
| Nov 16, 10 | Irish woes send FTSE 100 down 1%, but AstraZeneca climbs on sale hopes | | No data |
| Oct 28, 10 | Vodafone/Verizon speculation helps lift FTSE 100 | | No data |
| Oct 28, 10 | Standard Chartered up as FTSE holds on to gains | | No data |
| Oct 28, 10 | Shell up after beating forecasts | | No data |
| Oct 12, 10 | Standard Chartered adds 2% on bid talk, but FTSE dips on economic worries | | No data |
| Oct 11, 10 | David Brennan of AstraZeneca says public sector crucial to drug research | | No data |
| Sep 29, 10 | Dairy Crest jumps as Müller takes a stake, but FTSE 100 fades on economic worries | | No data |
| Sep 29, 10 | Vedanta Resources loses 5% as India orders copper smelter closure | | No data |
| Sep 27, 10 | Whitbread climbs on Costa spin-off talk, but FTSE falters as Irish debt worries grow | | No data |
| Sep 27, 10 | FTSE lifted by miners and Unilever but AstraZeneca dips on drug setback | | No data |
| Sep 15, 10 | AstraZeneca dips on US drug approval delay, as FTSE falters | | No data |